Results 31 to 40 of about 2,521 (195)
Visual Evoked Potential Findings in Endometriosis Patients Treated with Dienogest
, 2023 Purpose: The aim of the present study was to investigate possible toxic effects of Dienogest treatment on visual pathway among endometriosis patients using visual evoked potential (VEP) measurements.
Eslami Vaghar , Mohammad +1 more
core +1 more source
Case Reports in Obstetrics and Gynecology, 2018 A 27-year-old patient suffering from deeply infiltrating rectovaginal endometriosis was treated with 2 mg/day dienogest vaginally for 3 months. The therapy was tolerated very well.
Andreas D. Ebert
doaj +1 more source
Reproductive Medicine and Biology, 2020 Purpose Surgery for endometriomas may cause detrimental effects on ovarian reserve. We evaluated the safety of three‐step laparoscopic surgery for endometriomas utilizing dienogest in terms of post‐surgical ovarian reserve.
Michio Kitajima +6 more
doaj +1 more source
Germany Endometriosis Pattern Changes; Prevalence and Therapy over 2010 and 2019 Years: A Retrospective Cross Sectional Study [PDF]
International Journal of Fertility and Sterility, 2022 Background: The aim of this study was to investigate whether the prevalence and the therapy patterns of endometriosis differ in 2010 and 2019. Materials and Methods: This retrospective cross-sectional study was based on the data from the IQVIA Disease ...
Jacob Goehring +3 more
doaj +1 more source
The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery:a Systematic Review and Meta-Analysis [PDF]
, 2023 The objective of this study is to determine whether dienogest therapy after endometriosis surgery reduces the risk of recurrence compared with placebo or alternative treatments (GnRH agonist, other progestins, and estro-progestins).
Kontopantelis, Evangelos +10 more
core +1 more source
Dienogest and the Risk of Reoperation in Endometriosis [PDF]
Journal of Personalized Medicine, 2021 Background: This retrospective cohort study aimed to determine whether there is a difference in reoperation rates between patients who used dienogest (DNG) and patients who did not use DNG. Methods: Using Health Insurance Review and Assessment Service (HIRA) data generated between 1 January 2010 and 30 June 2018, we identified women with an ...
Yong-Soo Seo +3 more
openaire +2 more sources
Postoperative management of patients with endometriosis
Акушерство, гинекология и репродукция, 2020 Aim: to assess the effectiveness of using dienogest in combination with postoperative interventions in patients with endometriosis.Materials and methods.
Ju. E. Dobrokhotova +2 more
doaj +1 more source
Membranous dysmenorrhea and decidual casts: A scoping review
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Background Membranous dysmenorrhea, characterized by the expulsion of intact endometrial tissue rather than gradual dissolution during menstruation, occasionally presents as a decidual cast—a complete triangular mold of the uterine cavity. This poorly understood condition is likely underdiagnosed.
Lovisa Brehmer, Hedvig Engberg
wiley +1 more source
Estradiol Valerate/Dienogest: A Novel Oral Contraceptive
, 2011 Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of the new oral contraceptive estradiol valerate/dienogest. Data Sources: Searches of PubMed (1966-July 2011) and International Pharmaceutical Abstracts (1970-July 2011) were ...
Renee Rose, Karen L Whalen
core +1 more source
Reproductive Biology and Endocrinology, 2018 Background Current medical treatments for endometriosis are very limited. Progestin and selective progesterone receptor modulators (SPRM) are developed but their efficacy, safety, mechanism and recurrence in endometriosis are not fully studied.
Bo Liang +6 more
doaj +1 more source